Retrospective Chart Review Study of voxelotor in Sickle cell disease
Latest Information Update: 30 Oct 2020
At a glance
- Drugs Voxelotor (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 30 Oct 2020 New trial record
- 26 Oct 2020 According to a Global Blood Therapeutics Media Release, data from this trial were consistent with the results of our Phase 3 HOPE Study.
- 26 Oct 2020 According to a Global Blood Therapeutics Media Release, real-world effectiveness data from this trial will be presented as n oral presentation in the 15th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT).